Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Neuro-Oncology
•
Stereotactic Radiosurgery
What rate of second malignancies do you quote for patients receiving radiosurgery for benign CNS tumors?
Answer from: Radiation Oncologist at Community Practice
<1% at 10 years based on following Lancet Oncology paper: https://www.ncbi.nlm.nih.gov/pubmed/30473468
Comments
Radiation Oncologist at Bismarck Cancer Center
Agree - timely question given recency of the publi...
Radiation Oncologist at Radiant Oncology
Thank you both for the references! At the core of ...
Radiation Oncologist at Bismarck Cancer Center
That's a good question, and I agree with your conc...
Radiation Oncologist at Bismarck Cancer Center
(apologies, cut off) I think your non-threshold l...
Radiation Oncologist at Bismarck Cancer Center
up to 1% at 10y and 1-2% at 20y is a pretty reason...
1275
1276
1277
1278
1279
Sign In
or
Register
to read more
5029
Related Questions
Are you offering Lutathera for multiple recurrent meningiomas?
How would you approach a patient with recurrent grade 3 oligodendroglioma (MGMT-methylated, IDH mutant, 1p/19q co-deleted) 1 year after gross total resection and adjuvant chemotherapy and radiation?
How do you balance short-term efficacy against increased low-grade toxicity and quality-of-life considerations for higher single-fraction regimens in recurrent glioma patients?
Would patients receiving targeted therapies be eligible for TTFields for brain metastases?
How would you manage a recurrent meningioma of the cervical spine after resection alone?
Do you see MR Linac having a role in the treatment of CNS disease?
Would you treat an enlarging metastasis of the brainstem/upper cervical spinal cord with SRS in the setting of widespread disease and prior WBRT?
What cochlear dose constraint (if any) would you use when treating an acoustic neuroma without serviceable hearing on that side?
Is there a role for bevacizimab (IV or IA) for steroid refractory radionecrosis for AVM?
What is the role of radiation in intra labyrinthine (cochlear) schwannoma?
Agree - timely question given recency of the publi...
Thank you both for the references! At the core of ...
That's a good question, and I agree with your conc...
(apologies, cut off) I think your non-threshold l...
up to 1% at 10y and 1-2% at 20y is a pretty reason...